UN walks back 14,000 Gaza baby death claim after backlash
The United Nations has backtracked on a widely reported claim made by its humanitarian chief, Tom Fletcher, that 14,000 babies in Gaza could die within 48 hours if aid didn't reach them, a figure now confirmed to reflect a longer-term estimate.
Speaking to the BBC on Tuesday, Fletcher had said: 'There are 14,000 babies that will die in the next 48 hours unless we can reach them,' citing stalled aid trucks at the border carrying baby food and nutritional supplements. When asked how he arrived at that number, Fletcher responded that 'strong teams on the ground' were assessing the humanitarian situation from medical centres and schools.
However, the BBC later confirmed that the figure was based on an Integrated Food Security Phase Classification (IPC) report that estimated around 14,100 cases of severe acute malnutrition among children aged six to 59 months over a year-long period, from April 2025 to March 2026.
The report did not suggest that these children would die within 48 hours.
According to the
Jerusalem Post
, the UN Office for the Coordination of Humanitarian Affairs (UNOCHA) later clarified that while the figure was accurate, the time frame was not.
UNOCHA was quoted saying by the BBC, 'We need to get the supplies in as soon as possible, ideally within the next 48 hours,' emphasising urgency but not predicting mass deaths in that span.
Despite the clarification, Fletcher's original statement sparked international concern and was cited by at least nine UK Members of Parliament, according to the
Jewish Chronicle
. Critics, especially pro-Israel voices, accused Fletcher of inflating numbers to pressure Israel. Former Israeli government spokesperson Eylon Levy labelled the figure 'a hoax' on X.
The controversy unfolded as Israel reopened aid access into Gaza on May 18 after halting it post-ceasefire in early March.
On Tuesday, around 93 UN-inspected trucks carrying flour, baby food, medical gear and pharmaceuticals were allowed in,
Newsweek
reported. Fletcher called this 'a drop in the ocean,' warning that significantly more aid was still urgently needed.
Fletcher also rejected Israel's new plan to direct aid through a designated 'Hamas-free' zone in southern Gaza, calling it a 'dodgy modality.' He insisted the previous method of distributing aid worked better, adding: 'To go with the other modality would be to support the objectives of the military offensive.'
Amid increasing international pressure, UK foreign secretary David Lammy announced a suspension of trade talks with Israel, calling its recent military escalation 'morally unjustifiable.' UK Prime Minister Keir Starmer described the situation as 'utterly intolerable,' adding, 'We cannot allow the people of Gaza to starve.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
World's first human spinal cord implant to take place in Israel
Tel Aviv: Israel is preparing to perform the world's first-ever human spinal cord implant using a patient's own cells, a medical breakthrough that could allow paralysed patients to stand and walk again, Tel Aviv University announced on Wednesday. The surgery, expected in the coming months, will take place in Israel and marks a historic milestone in regenerative medicine . According to the World Health Organisation, over 15 million people worldwide are living with spinal cord injuries , with the majority resulting from traumatic causes such as falls, road traffic accidents, and violence. Currently, spinal cord injuries cannot be fully cured, so treatment focuses on stabilising the patient, preventing further damage, and maximising function. Emergency care often involves immobilising the spine, reducing inflammation, and sometimes performing surgery to repair fractures or relieve pressure. Rehabilitation includes physical and occupational therapy, as well as assistive devices like wheelchairs and braces. While experimental therapies--including stem cells and robotic devices--are being explored, no treatment yet reliably restores full spinal cord function. Spinal cord injuries are one of the few human injuries where the body cannot naturally heal itself, and the tissue is both structurally complex and extremely sensitive. "The spinal cord transmits electrical signals from the brain to all parts of the body. When it is severed by trauma such as a car accident, a fall, or a combat injury, the chain is broken. Think of an electrical cable that has been cut: when the two ends no longer touch, the signal cannot pass, and the patient remains paralysed below the injury," explained Professor Tal Dvir, head of the Sagol Centre for Regenerative Biotechnology and the Nanotechnology Centre at Tel Aviv University, who is leading the effort. Dvir is also the chief scientist at Matricelf , the Israeli biotech company commercialising the technology. Unlike other tissues, spinal cord neurons cannot naturally regenerate, and over time, scar tissue blocks remaining signals. The new procedure aims to replace the damaged section with a lab-grown spinal cord that fuses with healthy tissue above and below the injury. Animal studies in rats have shown remarkable results, with the animals regaining the ability to walk normally. The innovation began about three years ago, when Dvir's lab engineered a personalised three-dimensional human spinal cord in the laboratory. The findings, published in the peer-reviewed journal Advanced Science, showed that mice with chronic paralysis regained mobility after receiving the engineered implants. The procedure begins with blood cells from the patient, which are reprogrammed into stem-cell-like cells capable of becoming any cell type. Fat tissue is also collected to create a custom hydrogel scaffold, into which the stem-like cells develop into a spinal cord structure. This engineered tissue is then implanted, replacing scarred areas and reconnecting the nervous system. A few months ago, Prof. Dvir and his team received preliminary approval from Israel's Ministry of Health for "compassionate use" trials in eight patients, making Israel the first country to attempt this procedure. "This is undoubtedly a matter of national pride. The technology was developed here in Israel, at Tel Aviv University and at Matricelf, and from the very beginning it was clear to us that the first-ever surgery would be performed in Israel, with an Israeli patient," Dvir said. The technology was then commercialised through Matricelf, which was founded in 2019 under a licensing agreement with Tel Aviv University's technology transfer company, Ramot. "This milestone marks the shift from pioneering research to patient treatment. Using each patient's own cells eliminates key safety risks and positions Matricelf at the forefront of regenerative medicine. This first procedure is more than a scientific breakthrough; it is a step toward transforming an area of medicine long considered untreatable," said Matricelf CEO Gil Hakim. He added, "If successful, this therapy could define a new standard of care in spinal cord repair, addressing a multi-billion-dollar market with no effective solutions today. We are proud that Israel is leading this global effort and are fully committed to bringing this innovation to patients worldwide." "Our goal is to help paralysed patients rise from their wheelchairs. The animal model trials showed extraordinary success, and we are hopeful that the results in humans will be just as promising," Dvir said.
Hindustan Times
6 hours ago
- Hindustan Times
Microsoft boss warns of ‘AI psychosis' as users blur reality: What you need to know before trusting your AI companion
As artificial intelligence becomes part of daily life, a new risk is emerging. Microsoft's Mustafa Suleyman recently voiced his concerns about 'AI psychosis' on X (formerly Twitter), highlighting a mental health threat few had anticipated. According to Suleyman, there is growing evidence that some people are losing touch with reality when interacting with advanced chatbots, mistaking them for sentient beings or close companions. AI psychosis is under scrutiny after stories of users losing touch with reality through chatbots.(AI generated) How AI psychosis is unfolding BBC has documented real cases where people's connection to reality became dangerously blurred after using AI chatbots. One man from Scotland, called Hugh, shared his experience after using ChatGPT to get career advice. The chatbot not only validated his feelings but encouraged unrealistic beliefs, including a rapid path to fame and financial success. The constant validation led Hugh into deeper confusion, requiring professional help before he recognised what had happened. He told the BBC that, while AI tools can be useful, they become dangerous when people start to rely solely on them and drift away from reality. Individuals risk developing intense emotional attachments or falling into delusional thinking after spending long hours with AI chatbots. These accounts highlight a psychological risk that mental health professionals should not ignore. As AI-powered chatbots become more convincing and pervasive, they have the potential to amplify people's existing worries, support unrealistic beliefs or provide a false sense of companionship. The concern is not restricted to a handful of vulnerable users; given the widespread adoption of such technology, even a small percentage of affected individuals could amount to a significant public health challenge. As society rapidly weaves these digital agents into everything from personal advice to workplace routines, it becomes vital to acknowledge the genuine mental pressure that can come from sustained, emotionally charged interactions with non-human entities. The quality of our psychological and social 'diet,' much like our food intake, now relies just as much on the company we keep, real or virtual. Regular self-reflection, consistent engagement with real-life relationships and a healthy scepticism towards AI's abilities will be crucial in maintaining mental well-being. Why concern is widespread Mustafa Suleyman, on X, cautioned that there is 'zero evidence of AI consciousness today.' He warned that simply perceiving AI as conscious puts users at risk of believing that illusion. Suleyman called out companies for suggesting their AI is sentient, arguing that both developers and the AI itself should never promote this idea. Medical and academic voices echo his warning. Some doctors may soon routinely ask about patients' AI usage in mental health checkups. Public surveys cited by BBC show people are wary of AI passing as real humans, even though many are comfortable with lifelike voices. However, it's important to remember that chatbots may seem convincing but cannot truly feel, understand, or care in human ways. While these tools can be helpful, turning to family, friends, or real-world support remains essential when navigating emotional challenges.
Economic Times
19 hours ago
- Economic Times
Israel to launch world's first human spinal cord transplant using patient's own cells
Israel is set to perform the world's first spinal cord transplant using a patient's own cells, marking a historic milestone in regenerative medicine. The process focuses on repairing damaged neural pathways, restoring mobility, and improving quality of life for patients with spinal injuries, setting a new global standard for innovative medical diagnosis. Tired of too many ads? Remove Ads A Revolutionary Surgical Approach Impact on Patients' Lives Israel's Role in Medical Innovation Tired of too many ads? Remove Ads FAQs: In a groundbreaking development in regenerative medicine Israeli scientists are getting ready to perform the world's first spinal cord transplant using a patient's own cells. Announced on August 20, 2025, by Tel Aviv University , this pioneering procedure could redefine the treatment options for spinal cord injury diagnosis and give new hope for patients who have long faced restricted surgery will involve transplanting a patient's own cells into the damaged areas of the spinal cord. The aim is to restore lost functions, allowing patients to regain mobility. Unlike traditional treatments that rely on donor tissues or artificial implants, this process leverages the patient's biological material, minimizing the risk of rejection and enhancing the chances of successful regard that this approach represents a major leap forward in spinal cord therapy. By leveraging the patient's own cells, doctors focus to stimulate neural regeneration and repair, allowing individuals to walk again after severe injuries. If successful, the process could set a global precedent for how spinal cord injuries are diagnosed in the cord injuries usually result in permanent loss of sensation and movement, then affecting quality of life. The innovative transplant will mitigate these effects by repairing neural pathways and initiating recovery. For patients and families who have faced the long-term issues of immobility, this breakthrough could bring renewed hope for rehabilitation and renewed has long been at the forefront of medical research, with advancements spanning oncology, cardiology, and neurology. The upcoming spinal cord transplant highlights the country's commitment to pioneering answers that push the boundaries of conventional medicine. Collaboration between Tel Aviv University and leading medical institutions demonstrates how academic research can be translated into clinical practice, benefiting patients worldwide.A1. A spinal cord transplant is a medical process that focuses to repair damaged spinal tissue, restore lost neural functions, and potentially enable patients to regain mobility.A2. Regenerative medicine uses the body's own cells or biological materials to repair, replace, or regenerate damaged tissues and organs, initiating natural healing and recovery.
